On September 28, 2022, the company announced that it has extended its plan duration till October 2, 2042.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10,670 KRW | -1.57% | -3.87% | -9.35% |
2023 | Jeil Pharma Holdings Inc Reports Earnings Results for the First Quarter Ended March 31, 2023 | CI |
2022 | Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042. | CI |
1st Jan change | Capi. | |
---|---|---|
-9.35% | 12Cr | |
+21.28% | 4.44TCr | |
+24.60% | 2.3TCr | |
+17.89% | 1.51TCr | |
+12.87% | 1.31TCr | |
+44.67% | 1.19TCr | |
-8.33% | 698.92Cr | |
-0.05% | 678.76Cr | |
-8.87% | 572.55Cr | |
+12.22% | 551.54Cr |
- Stock Market
- Equities
- A002620 Stock
- News Jeil Pharma Holdings Inc
- Jeil Pharma Holdings Inc's Equity Buyback Plan Extended till October 2, 2042.